Seroprevalence ofBordetella pertussisin patients with COPD in a UK cohort
Open Access
- 27 February 2025
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (3)
Abstract
Exacerbations are key events in the natural history of COPD as they contribute to lung function decline and therefore disease progression [1]. Exacerbations are heterogeneous and it is well-described that exacerbations of COPD may be caused by bacterial infections, viral infections, eosinophilic inflammation, exogenous toxins such as air pollution and worsening of comorbidities [2, 3]. Some causes of exacerbation are preventable with pharmacotherapy and vaccination, but many are not [4]. Therefore, identifying potentially preventable causes of COPD exacerbation is important to reduce the burden of disease [5].Keywords
Funding Information
- GlaxoSmithKline
This publication has 10 references indexed in Scilit:
- Simplifying pharmacotherapy for patients with COPD: a viewpointEuropean Respiratory Journal, 2023
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive SummaryEuropean Respiratory Journal, 2023
- ERJ advances: state of the art in definitions and diagnosis of COPDEuropean Respiratory Journal, 2023
- Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”American Journal of Respiratory and Critical Care Medicine, 2022
- ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbationsEuropean Respiratory Journal, 2021
- Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS CohortCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2021
- Burden of Pertussis in COPD: A Retrospective Database Study in EnglandCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2021
- Clinically Diagnosing Pertussis-associated Cough in Adults and ChildrenChest, 2019
- Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claimsEpidemiology and Infection, 2017
- Pertussis vaccines: WHO position paper, August 2015—RecommendationsVaccine, 2016